This study examined whether people who started a glucagon-like peptide-1 receptor agonist (GLP-1) like Zepbound or Ozempic were less likely to develop a substance use disorder, and whether people who already had a substance use disorder had fewer serious complications
Pharmacokinetic and Pharmacodynamic Studies: Conduct comprehensive studies to understand how BPC-157 is absorbed, distributed, metabolized, and excreted in humans, and how it interacts with biological systems at different concentrations
Ingredients Recommended Use As a dietary supplement, take 1, 1-2 times daily, or as directed by your healthcare practitioner
Not yet, that is
Insulin resistance develops or worsens
Still, future clinical trials need novel ways based on biology to assess outcomes in clinical studies and to understand better how new drugs alter the causes of disease in patients with FA